MedPath

ADCETRIS

ADCETRIS

Approved
DIN Number

02401347

Drug Class

Human

Market Date

Feb 19, 2013

Company
HC

Seagen Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02401347
AIG Number0153680001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FX05 BRENTUXIMAB VEDOTIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BRENTUXIMAB VEDOTINActive
Strength: 50 MG / VIAL
Monograph: BRENTUXIMAB VEDOTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.